(Q34231354)

31 July 2017

title

How do women decide? Accepting or declining BRCA1/2 testing in a nationwide clinical sample in the United States (English)

1 reference

31 July 2017

main subject

United States of America

0 references

4

Mildred Cho

1 reference

31 July 2017

Pamela Sankar

1

1 reference

31 July 2017

Paul Root Wolpe

series ordinal

2

1 reference

31 July 2017

Nora L Jones

series ordinal

3

1 reference

31 July 2017

publication date

1 January 2006

1 reference

31 July 2017

published in

Public Health Genomics

1 reference

31 July 2017

volume

9

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

78-86

1 reference

A qualitative study of women's views on medical confidentiality

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1317096

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1317096

Early adoption of BRCA1/2 testing: who and why.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1317096

Intention to pursue genetic testing for breast cancer among women due for screening mammography.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1317096

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1317096

Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1317096

Collecting retrospective data: accuracy of recall after 50 years judged against historical records

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1317096

Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1159%2F000091484

Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1317096

BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1317096

Factors associated with decisions about clinical BRCA1/2 testing

28 October 2018

1 reference

12 December 2020

Evaluation of nurses and genetic counselors as providers of education about breast cancer susceptibility testing

1 reference

12 December 2020

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing

1 reference

12 December 2020

Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996

1 reference

12 December 2020

Interest in BRCA1/2 testing in a primary care population

1 reference

12 December 2020

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes

1 reference

12 December 2020

Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study

1 reference

12 December 2020

Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?

1 reference

12 December 2020

Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population

1 reference

12 December 2020

What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations

1 reference

12 December 2020

Identifiers

DOI

10.1159/000091484

1 reference

31 July 2017

1 reference

31 July 2017

1 reference